FrancophonIA/ELRC3.0 huggingface dataset:
English: The change in eye colour has predominantly been seen in patients with mixed coloured irides, i.e., blue-brown, grey-brown, yellow-brown and green-brown; however, it has also been observed in patients with brown eyes.
Croatian: Promjena boje oka uglavnom se opaža kod bolesnika s mješovito obojenim šarenicama, npr. plavo-smeđe, sivo-smeđe, žuto-smeđe i zeleno-smeđe te također i kod bolesnika sa smeđim očima.
English: In a 3 month phase 3 study and a 7 days pharmacokinetic study, involving 102 paediatric patients exposed to TRAVATAN, the types and characteristics of adverse reactions reported were similar to what has been observed in adult patients.
Croatian: U tromjesečnom ispitivanju faze 3 i sedmodnevnom ispitivanju farmakokinetike, koja su uključila 102 pedijatrijska bolesnika izložena TRAVATAN-u, vrste i karakteristike zabilježenih nuspojava bile su slične onima zabilježenim u odraslih bolesnika.
English: Opened (2)
Croatian: Otvoreno (2)
English: In the age groups 3 to < 12 years (n=36) and 12 to < 18 years (n=26), mean IOP reduction at Week 12 in the travoprost group was similar to that in the timolol group.
Croatian: U dobnim skupinama od 3 do <12 godina (n=36) i od 12 do <18 godina (n=26), srednja vrijednost sniženja IOT-a u 12. tjednu u skupini koja je primala travoprost bila je slična onoj u skupini koja je primala timolol.
English: In children and adolescents, the most common side effects seen with TRAVATAN are eye redness and growth of eyelashes.
Croatian: Kod djece i adolescenata, najčešće zabilježene nuspojave sa TRAVATAN-om bile su crvenilo oka i rast trepavica.
English: Following topical ocular administration of TRAVATAN to healthy volunteers, low systemic exposure to active free acid was demonstrated.
Croatian: Nakon topikalne okularne primjene TRAVATANA na zdravim dobrovoljcima opisana je niska sistemska izloženost aktivnoj slobodnoj kiselini.
English: Opened (3)
Croatian: Otvoreno (3)
English: TRAVATAN can be used in children from 2 months to < 18 years at the same dose as for adults.
Croatian: TRAVATAN se može primijeniti kod djece od 2 mjeseca do <18 godina u istoj dozi kao i kod odraslih.
English: The systemic metabolic pathways parallel those of endogenous prostaglandin F2 which are characterised by reduction of the 13-14 double bond, oxidation of the 15-hydroxyl and -oxidative cleavages of the upper side chain.
Croatian: Sistemski metabolički putevi paralelni su s onima endogenih prostaglandina F2α, za koje je karakteristična redukcija 13-14 dvostruke veze te oksidacija 15-hidroksilnih i β-oksidacijskih grana gornjeg postraničnog lanca.
English: Travoprost, a prostaglandin F2 analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways.
Croatian: Travoprost, analog prostaglandina F2α , je visoko selektivni potpuni agonist koji ima visoki afinitet za FP receptor prostaglandina i snižava intraokularni tlak povećanjem otjecanja očne vodice putem trabekularne mreže i uveoskleralnih puteva.
English: The safety and efficacy of TRAVATAN in children below the age of 2 months have not been established.
Croatian: Sigurnost i djelotvornost TRAVATANA u djece u dobi ispod 2 mjeseca nisu ustanovljene.
English: Each mL of solution contains polyquaternium-1 (POLYQUAD) 10 microgram, propylene glycol 7.5 mg, polyoxyethylene hydrogenated castor oil 40 (HCO-40) 2 mg (see section 4.4.)
Croatian: Svaki ml otopine sadrži 10 mikrograma polikvaternija-1 (POLYQUAD), 7,5 mg propilenglikola, 2 mg polioksietilen hidrogeniranog ricinusovog ulja 40 (HCO-40) (vidjeti dio 4.4.)
English: Travoprost significantly increased optic nerve head blood flow in rabbits following 7 days of topical ocular administration (1.4 micrograms, once-daily).
Croatian: Travoprost značajno povećava protok krvi kroz glavu optičkog živca u kunića nakon 7 dana topikalne primjene na oku (1,4 mikrograma, jednom dnevno).
English: However, data in the age group 2 months to < 3 years (9 patients) is limited (see section 5.1).
Croatian: Ipak, podaci o dobnoj skupini od 2 mjeseca do <3 godine (9 bolesnika) su ograničeni (vidjeti dio 5.1).
English: 1 What TRAVATAN is and what it is used for What you need to know before you use TRAVATAN How to use TRAVATAN
Croatian: Što je TRAVATAN i za što se koristi Što morate znati prije nego počnete primjenjivati TRAVATAN Kako primjenjivati TRAVATAN Moguće nuspojave
English: In a clinical trial, patients with open-angle glaucoma or ocular hypertension who were treated with TRAVATAN (polyquaternium-preserved) dosed once-daily in the evening demonstrated 8 to 9 mmHg reductions (approximately 33%) in intraocular pressure from 24 to 26 mmHg baseline.
Croatian: U kliničkim ispitivanjima, kod bolesnika s glaukomom otvorenog kuta ili očnom hipertenzijom koji su liječeni TRAVATANOM (polikvaternij kao konzervans) doziranim jednom dnevno uvečer, pokazano je smanjenje intraokularnog tlaka od 8 do 9 mmHg (otprilike 33%) u odnosu na početni tlak od 24 do 26 mmHg.
English: In clinical trials with TRAVATAN, the most common adverse reactions were ocular hypearemia and iris hyperpigmentation, occurring in approximately 20% and 6% of patients respectively.
Croatian: U kliničkim ispitivanjima s TRAVATANOM najčešće zabilježene nuspojave bile su okularna hiperemija i hiperpigmentacija irisa, a pojavile su se kod približno 20% odnosno 6% bolesnika.
English: Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1).
Croatian: Snižavanje povišenog intraokularnog tlaka u odraslih bolesnika s očnom hipertenzijom ili glaukomom otvorenog kuta (vidjeti dio 5.1).
English: Efficacy and safety data in the age group 2 months to < 3 years (9 patients) is limited (see section 5.1).
Croatian: Podaci o djelotvornosti i sigurnosti primjene u dobnoj skupini od 2 mjeseca do <3 godine (9 bolesnika) su ograničeni (vidjeti dio 5.1).
English: The primary efficacy endpoint was the intraocular pressure (IOP) change from baseline at Week 12 of the study.
Croatian: Primarni ishod djelotvornosti bila je promjena intraokularnog tlaka (IOT) u odnosu na početnu vrijednost u 12. tjednu ispitivanja.
English: Specific in vitro interaction studies were performed with TRAVATAN and medicinal products containing thiomersal.
Croatian: Provedene su specifične in vitro studije s TRAVATANOM i drugim lijekovima koji sadrže tiomersal.
English: The active substance is travoprost 40 micrograms/ml.
Croatian: - Djelatna tvar je travoprost 40 mikrograma/ml.
English: Do not stop taking TRAVATAN without speaking to your doctor.
Croatian: Nemojte prekidati primjenu TRAVATANA bez prethodne konzultacije s Vašim liječnikom.
English: Rare: may affect up to 1 in 1,000 people
Croatian: Rijetke nuspojave: mogu se pojaviti u manje od 1 na 1000 osoba
English: The following side effects have been seen with TRAVATAN
Croatian: Slijedeće su nuspojave zabilježene s TRAVATANOM
English: The efficacy of TRAVATAN in paediatric patients from 2 months to less than 18 years of age was demonstrated in a 12-week, double-masked clinical study of travoprost compared with timolol in 152 patients diagnosed with ocular hypertension or paediatric glaucoma.
Croatian: Djelotvornost TRAVATANA u pedijatrijskih bolesnika od 2 mjeseca do manje od 18 godina starosti dokazana je u dvostruko maskiranom kliničkom ispitivanju usporedbe travoprosta u odnosu na timolol, u trajanju od 12 tjedana u 152 bolesnika s dijagnozom okularne hipertenzije ili pedijatrijskog glaukoma.
English: Caution is recommended when using Travatan in aphakic patients, pseudophakic patients with a torn posterior lens capsule or anterior chamber lenses, or in patients with known risk factors for cystoid macular oedema.
Croatian: Preporučuje se oprez kod primjene TRAVATANA u afakičnih bolesnika, pseudoafakičnih bolesnika s rupturom stražnje kapsule leće ili leća u prednjoj očnoj sobici ili kod pacijenata sa poznatim faktorima rizika za cistoidni makularni edem.
English: Macular oedema has been reported during treatment with prostaglandin F2a analogues.
Croatian: Makularni edem makule je zabilježen tijekom liječenja s analozima prostangladina F2.
English: TRAVATAN can be used in paediatric patients from 2 months to < 18 years at the same posology as in adults.
Croatian: TRAVATAN se može koristiti u pedijatrijskih bolesnika od 2 mjeseca do <18 godina u istim dozama kao i u odraslih.
English: Mean IOP reduction at Week 12 in the 2 months to < 3 years of age group was 1.8 mmHg in the travoprost group and 7.3 mmHg in the timolol group.
Croatian: Srednja vrijednost sniženja IOT-a u 12. tjednu u dobnoj skupini od 2 mjeseca do <3 godine bila je 1,8 mmHg u skupini koja je primala travoprost i 7,3 mmHg u skupini koja je primala timolol.
English: Studies in rabbits have shown peak concentrations of 20 ng/mL of the free acid in aqueous humour one to two hours after topical dosing of TRAVATAN.
Croatian: Studije na kunićima su pokazale vršnu koncentraciju od 20 ng/ml slobodnih kiselina u očnoj vodici 1 do 2 sata nakon topikalne primjene TRAVATANA.
English: Skin contact with TRAVATAN must be avoided as transdermal absorption of travoprost has been demonstrated in rabbits.
Croatian: Dodir TRAVATANA s kožom se mora izbjegavati, budući da je kod kunića opažena transdermalna apsorpcija travoprosta.
English: Effects in the eye: inflammation of the back of the eye, eyes appear more inset.
Croatian: Nuspojave na oku: upala stražnjeg dijela oka, izgled upalih očiju.
English: Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1).
Croatian: Snižavanje povišenog intraokularnog tlaka u pedijatrijskih bolesnika u dobi od 2 mjeseca do <18 godina s očnom hipertenzijom ili pedijatrijskim glaukomom (vidjeti dio 5.1).
English: In 4 previous systemic pharmacokinetic studies in adult populations, travoprost free acid plasma concentrations ranged from BLQ to 52.0 pg/mL.
Croatian: U 4 ranija ispitivanja sistemske farmakokinetike u odrasloj populaciji, koncentracija travoprost slobodne kiseline u plazmi bila je u rasponu od BLQ do 52,0 pg/ml.
English: Write down the date you opened it in the space on the carton box.
Croatian: Zapišite datum otvaranja na kutiji u predviđenom prostoru
English: A pharmacokinetic study in paediatric patients aged 2 months to < 18 years demonstrated very low plasma exposure to travoprost free acid, with concentrations ranging from below the 10 pg/mL assay limt of quantitation (BLQ) to 54.5 pg/mL.
Croatian: Ispitivanje farmakokinetike u pedijatrijskih bolesnika u dobi od 2 mjeseca do <18 godina pokazalo je vrlo nisku izloženost travoprost slobodnoj kiselini u plazmi, s koncentracijama u rasponu od ispod 10 pg/ml granice kvantifikacije testa (BLQ) do 54,5 pg/ml.
English: Each mL of solution contains 40 micrograms of travoprost.
Croatian: Svaki ml otopine sadrži 40 mikrograma travoprosta.
English: TRAVATAN preserved with polyquaternium-1 induced minimal ocular surface toxicity, compared to eye drops preserved with benzalkonium chloride, on cultured human corneal cells and following topical ocular administration in rabbits.
Croatian: TRAVATAN konzerviran s polikvaternij-1 inducira minimalnu toksičnost na očnoj površini u usporedbi s kapima za oko konzerviranim s benzalkonijevim kloridom, na kulturi ljudskih stanica rožnice i nakon topikalne primjene u oko kunića.
English: Findings are related to FP receptor agonist activity in uterus with early embryolethality, post-implantation loss, foetotoxicity.
Croatian: Nalazi su ovisni o aktivnosti agonista FP receptora u uterusu i uključuju ranu smrtnost embrija, postimplantacijski gubitak i fetotoksičnost.
English: Table 1 Comparison of Mean IOP Change from Baseline (mmHg) at Week 12
Croatian: Tablica 1 Usporedba srednje vrijednosti promjene IOT-a u odnosu na početnu vrijednost (mmHg) u 12. tjednu
English: TRAVATAN contains polyoxyethylene hydrogenated castor oil 40 which may cause skin reactions.
Croatian: TRAVATAN sadrži polioksietilen hidrogenirano ricinusovo ulje 40 koje može uzrokovati reakcije kože.
English: Peak active free acid plasma concentrations of 25 pg/mL or less were observed between 10 and 30 minutes post-dose.
Croatian: Zabilježena je vršna koncentracija aktivne slobodne kiseline u plazmi od 25 pg/ml ili manje 10-30 minuta nakon primjene doze.
English: Not known prostatic specific antigen increased
Croatian: Nepoznato povišenje vrijednosti prostata specifičnog antigena
English: Data on adjunctive administration of TRAVATAN with timolol 0.5% and limited data with brimonidine 0.2% were collected during clinical trials that showed an additive effect of TRAVATAN with these glaucoma medications.
Croatian: Tijekom kliničkih pokusa sakupljeni podaci o dodatnoj terapiji TRAVATANA s timololom 0,5% i ograničeni podaci s brimonidinom 0,2% pokazali su aditivni učinak TRAVATANA s ovim lijekovima za glaukom.
English: Rare dermatitis allergic, dermatitis contact, erythema, rash, hair colour changes, madarosis
Croatian: Rijeko alergijski dermatitis, kontaktni dermatitis, eritem, osip, promjene boje dlaka, madaroza
English: Estimates based on least squares means derived from a statistical model that accounts for correlated IOP measurements within patient where primary diagnosis and baseline IOP stratum are in the model.
Croatian: Procjene su temeljene na srednjim vrijednostima po metodi najmanjih kvadrata, izvedene iz statističkog modela koji uzima u obzir korelaciju mjerenja IOT-a za pojedinog bolesnika, pri čemu su u model unesene primarna dijagnoza i početna vrijednost IOT-a.
English: Periorbital and eye lid changes
Croatian: Periorbitalne promjene i promjene na vjeđama
English: If you stop using TRAVATAN
Croatian: Ako prestanete primjenjivati TRAVATAN
English: It could infect the drops
Croatian: Može doći do kontaminacije kapi.
English: • Only use one bottle at a time.
Croatian: • Koristite samo jednu bočicu prije otvaranja druge bočice.
English: Travoprost has harmful pharmacological effects on pregnancy and/or the fetus/new-born child. TRAVATAN should not be used during pregnancy unless clearly necessary.
Croatian: Travoprost ima štetne farmakološke učinke na trudnoću i/ili fetus/novorođenče.
English: The use of TRAVATAN by breast-feeding mothers is not recommended.
Croatian: Primjena TRAVATAN kapi kod dojilja nije preporučena.
English: • Immediately before using a bottle for the first time, tear open the overwrap pouch, take the bottle out (picture 1) and write the date of opening on the carton in the space provided
Croatian: • Zaštitni omot (vrećicu) rastvorite neposredno prije prve primjene i izvadite bočicu (slika 1).
English: TRAVATAN contains hydrogenated castor oil and propylene glycol which may cause skin reactions and irritation.
Croatian: TRAVATAN sadrži hidrogenirano ricinisuovo ulje i propilenglikol koji mogu uzrokovati kožne reakcije i iritaciju.
English: If you forget to use TRAVATAN
Croatian: Ako ste zaboravili primijeniti TRAVATAN
English: The other ingredients are Polyquaternium-1, polyoxyethylene hydrogenated castor oil 40, propylene glycol, sodium chloride, boric acid, mannitol and purified water.
Croatian: - Drugi sastojci su polikvaternij-1, polioksietilen hidrogenirano ricinusovo ulje 40, propilenglikol, natrijev klorid, boratna kiselina, manitol i pročišćena voda.
English: Pharmacotherapeutic group: Ophthalmologicals-antiglaucoma preparations and miotics-prostaglandin analogues
Croatian: Farmakoterapijska skupina: oftalmici - antiglaukomski lijekovi i miotici - analozi prostaglandina ATK oznaka: S01E E04
English: TRAVATAN has been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 ml/min).
Croatian: TRAVATAN je ispitivan u bolesnika s blagim do teškim oštećenjem funkcije jetre kao i u bolesnika s blagim do teškim oštećenjem bubrega (najniži klirens kreatinina 14 ml/min).
English: TRAVATAN contains propylene glycol which may cause skin irritation.
Croatian: TRAVATAN sadrži propilenglikol koji može uzrokovati iritaciju kože.
English: No data are available for children less than 2 months old.
Croatian: Nema podataka za djecu ispod 2 mjeseca starosti.
English: In controlled clinical trials, periorbital and/or eyelid skin darkening in association with the use of TRAVATAN has been reported in 0.4% of patients.
Croatian: Kontrolirana klinička ispitivanja ukazuju na periorbitalno tamnjenje i/ili tamnjenje kože vjeđa kod 0,4% bolesnika, povezano s primjenom TRAVATANA.
English: • If you wear soft contact lenses, do not use the drops with your lenses in. After using the drops wait 15 minutes before putting your lenses back in.
Croatian: • Ako nosite meke kontaktne leće, ne primjenjujte kapi dok su leće u oku.
English: If you're worried, talk to a doctor or pharmacist.
Croatian: Budete li zabrinuti, obratite se za savjet liječniku ili ljekarniku.
English: Use of TRAVATAN is not recommended to those children under 2 months of age.
Croatian: Ne preporučuje se primjena TRAVATANA u djece ispod 2 mjeseca starosti.
English: What TRAVATAN looks like and contents of the pack TRAVATAN is a liquid (a clear, colourless solution) supplied in a pack containing a 4 ml plastic bottle with a screw cap. Each bottle contains 2.5 mL of travoprost eye drops and each bottle is placed in a pouch.
Croatian: TRAVATAN je tekućina (bistra, bezbojna otopina) dostupna u pakiranju koje sadrži plastičnu bočicu od 4 ml sa zatvaračem s navojem.
English: There is no experience of TRAVATAN in inflammatory ocular conditions; nor in neovascular, angle-closure, narrow-angle or congenital glaucoma and only limited experience in thyroid eye disease, in open-angle glaucoma of pseudophakic patients and in pigmentary or pseudoexfoliative glaucoma.
Croatian: Postoji samo ograničeno iskustvo u tiroidnoj bolesti oka, u glaukomu otvorenog kuta pseudofakičnih bolesnika i kod pigmentnog ili pseudoeksfolijativnog glaukoma.
English: 1 mL of solution contains 40 micrograms of travoprost
Croatian: 1 ml otopine sadrži 40 mikrograma travoprosta.
English: How to use TRAVATAN
Croatian: Kako primjenjivati TRAVATAN
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE OMOT
English: 1 bottle of 2.5 mL 3 bottles of 2.5 mL
Croatian: 1 x bočica od 2,5 ml 3 x bočica od 2,5 ml
English: The adverse reactions were obtained from clinical studies and postmarketing data with TRAVATAN.
Croatian: Nuspojave su zabilježene u kliničkim ispitivanjima i praćenju TRAVATANA nakon stavljanja u promet.
English: No data are available for children below the age of 2 months.
Croatian: Nema podataka za djecu u dobi ispod 2 mjeseca.
English: The dose is one drop of TRAVATAN in the conjunctival sac of the affected eye(s) once daily.
Croatian: Primjena u odraslih, uključujući stariju populaciju Doza je jedna kap TRAVATANA jednom dnevno u konjunktivalnu vrećicu oboljelog(ih) oka(očiju).
English: CARTON FOR SINGLE BOTTLE 2.5 ml + CARTON FOR 3x2.5 ml BOTTLES
Croatian: KUTIJA ZA JEDNU BOČICU OD 2,5 ml + KUTIJA ZA 3 BOČICE x 2,5 ml
English: General side effects: increased allergic symptoms, headache, irregular heart beat, cough, stuffy nose, throat irritation, darkening of skin around the eye (s), skin darkening, abnormal hair texture, excessive hair growth.
Croatian: Opće nuspojave: pojačani simptomi alergije, glavobolja, nepravilni otkucaji srca, kašalj, začepljen nos, nadražaj grla, tamnjenje kože oko oka (očiju), tamnjenje kože, abnormalna tekstura dlaka, pojačan rast dlaka.
English: • Close the bottle cap firmly immediately after use
Croatian: • Dobro zatvorite zatvarač bočice nakon primjene.
English: TRAVATAN has been shown to cause slight enlargement of the palpebral fissure in studies in the monkey.
Croatian: U ispitivanjima s majmunima pokazano je da TRAVATAN uzrokuje lagano povećanje palpebralne fisure.
English: • Gently squeeze the bottle to release one drop of TRAVATAN at a time.
Croatian: • Lagano stisnite bočicu tako da isteče po jedna kap lijeka TRAVATAN (slika 3)
English: 4 mL oval Polypropylene (PP) or Low Density Polyethylene (LDPE) bottle and PP or LDPE dispensing plug with a PP screw cap, presented in an overwrap.
Croatian: Ovalna bočica od polipropilena ili polietilena niske gustoće volumena 4 ml, s nastavkom za kapanje od polipropilena ili polietilena niske gustoće i polipropilenskim zatvaračem s navojem, u omotu.
English: Uncommon cough, nasal congestion, throat irritation Rare dyspnoea, asthma, respiratory disorder, oropharyngeal pain, dysphonia, rhinitis allergic, nasal dryness
Croatian: Rijetko dispneja, astma, respiratorni poremećaj, orofaringealna bol, disfonija, alergijski rinitis, suhoća sluznice nosa
English: Alcon Cusí, S.A., Camil Fabra 58, 08320 El Masnou, Barcelona, Spain
Croatian: Camil Fabra 58 08320 El Masnou Barcelona Španjolska
English: Do not use TRAVATAN if you are breast feeding.
Croatian: Ne primjenjujte TRAVATAN ako dojite.
English: How to store TRAVATAN Contents of the pack and other information
Croatian: Kako TRAVATAN izgleda i sadržaj pakiranja
English: General side effects: depression, anxiety, insomnia, sensation of false movement, ringing in ears, chest pain, abnormal heart rhythm, increased heart beat, worsening of asthma, diarrhea, nose bleeds, abdominal pain, nausea, vomiting, itching, abnormal hair growth, painful or involuntary urination, increase in prostate cancer marker.
Croatian: Opće nuspojave: depresija, tjeskoba, nesanica, osjećaj lažnih pokreta, zvonjava u ušima, bol u prsnom košu, abnormalan srčani ritam, ubrzan rad srca, pogoršanje astme, proljev, krvarenje iz nosa, bol u trbuhu, mučnina, povraćanje, svrbež, abnormalan rast dlaka, bolno ili nekontrolirano mokrenje, povišene vrijednosti tumorskih markera prostate.
English: Rare iridocyclitis, ophthalmic herpes simplex, eye inflammation, photopsia, eczema eyelids, conjunctival oedema, halo vision, conjunctival follicles, hypoaesthesia eye, trichiasis, meibomianitis, anterior chamber pigmentation, mydriasis, asthenopia, eyelash hyperpigmentation, eyelash thickening
Croatian: Rijetko iridociklitis, očni herpes simplex, upala oka, fotopsija, ekcem vjeđa, konjunktivalni edem, pojava obojenih ili svjetlećih krugova oko izvora svjetlosti, konjunkitvalni folikuli, hipoestezija oka, trihijaza, meibomianitis, pigmentacija prednje očne sobice, midrijaza, astenopija, hiperpigmentacija trepavica, zadebljanje trepavica
English: S.A. Alcon-Couvreur N.V., Rijksweg 14,
Croatian: S.A. Alcon Couvreur N.V.
English: Effects in the eye: perception of flashing lights, eczema of the eyelids, abnormally positioned eyelashes that grow back toward the eye, eye swelling, reduced vision, halo vision, decreased eye sensation, inflammation of the glands of the eyelids, pigmentation inside the eye, increase in pupil size, eyelash thickening, change in eyelash colour, tired eyes.
Croatian: Nuspojave na oku: percepcija treperećeg svjetla, ekcem vjeđa, abnormalno smještene trepavice koje rastu natrag prema oku, oticanje oka, oslabljeni vid, pojava obojenih ili svjetlećih krugova oko izvora svjetlosti, smanjeni osjet oka, upala žlijezda na vjeđama, pigmentacija u unutrašnjosti oka, povećanje veličine zjenice, zadebljanje trepavica, promjena u boji trepavica, umorne oči.
English: General side effects: eye viral infection, dizziness, bad taste, irregular or decreased heart rate, increased or decreased blood pressure, shortness of breath, asthma, nasal allergy or inflammation, nasal dryness, voice changes, gastrointestinal discomfort or ulcer, constipation, dry mouth, redness or itching of the skin, rash, hair colour change, loss of eyelashes, joint pain, musculoskeletal pain, generalised weakness.
Croatian: Opće nuspojave: virusna infekcija oka, omaglica, neugodan okus u ustima, nepravilna ili smanjena srčana frekvencija, kašalj, povišeni ili sniženi krvni tlak, nedostatak zraka, astma, nosna alergija ili upala, suhoća sluznice nosa, promjene glasa, nelagoda u probavnom sustavu ili vrijed, zatvor, suha usta, crvenilo ili svrbež kože, osip, promjena boje dlaka, gubitak trepavica, bol u zglobovima, mišićnokoštana bol, opća slabost.
English: Posology
Croatian: PODACI